NDC 0023-4291

LASTACAFT

Alcaftadine

LASTACAFT is a Ophthalmic Solution/ Drops in the Human Otc Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Alcaftadine.

Product ID0023-4291_3110f1f0-8f7d-425b-8ed5-99673f085be6
NDC0023-4291
Product TypeHuman Otc Drug
Proprietary NameLASTACAFT
Generic NameAlcaftadine
Dosage FormSolution/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2021-12-01
Marketing CategoryNDA /
Application NumberNDA022134
Labeler NameAllergan, Inc.
Substance NameALCAFTADINE
Active Ingredient Strength3 mg/mL
Pharm ClassesHistamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0023-4291-01

1 BOTTLE, PLASTIC in 1 CARTON (0023-4291-01) > 1 mL in 1 BOTTLE, PLASTIC
Marketing Start Date2021-12-01
NDC Exclude FlagN
Sample Package?Y

Drug Details

NDC Crossover Matching brand name "LASTACAFT" or generic name "Alcaftadine"

NDCBrand NameGeneric Name
0023-4290LASTACAFTalcaftadine
0023-4291LASTACAFTalcaftadine
42254-288LASTACAFTalcaftadine

Trademark Results [LASTACAFT]

Mark Image

Registration | Serial
Company
Trademark
Application Date
LASTACAFT
LASTACAFT
85168259 4071760 Live/Registered
Allergan, Inc.
2010-11-03
LASTACAFT
LASTACAFT
85088422 4003795 Live/Registered
Allergan, Inc.
2010-07-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.